New Non-Small Cell Lung Cancer Study at Johns Hopkins University
Read MoreSEngine Precision Medicine Partners with Vincere Cancer Center to Increase Access for First Responders to Get Personalized Cancer Treatments via the PARIS® Test
Read MoreDana Farber Collaboration to Bring PARIS® Test to Patients with CNS Cancers
Read MorePARIS® Test Identified Effective Therapy for Patient with Terminal Ovarian Cancer
Read MoreProspective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug testing and 3D tumor cell culture.
Read MoreStrong Predictive Value of Organoid-Based PARIS® Test to Identify Personalized Treatments in Advanced Cancers Presented at 2021 ASCO Annual Meeting
Read MoreSEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS® Test at 2021 ASCO Annual Meeting
Read MoreSEngine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian Cancer
Read MorePredictive Value of PARIS® Test in Ovarian Cancer Patients at 2021 AACR Annual Conference
Read More